tiprankstipranks
Advertisement
Advertisement

ENSC Stock Latest News

Ensysce Biosciences awarded $5.3M installment in NIDA funding
The FlyEnsysce Biosciences awarded $5.3M installment in NIDA funding
4d ago
ENSC
Ensysce Biosciences enrolls first patient in final stage of PF614-MPAR-102
PremiumThe Fly
Ensysce Biosciences enrolls first patient in final stage of PF614-MPAR-102
22d ago
ENSC
Ensysce Biosciences files to sell 1.3M shares of common stock for holders
PremiumThe Fly
Ensysce Biosciences files to sell 1.3M shares of common stock for holders
1M ago
ENSC
Ensysce announces expansion of patent protection for MPAR technology
PremiumThe Fly
Ensysce announces expansion of patent protection for MPAR technology
2M ago
ENSC
Ensysce secures IRB approval of final phase of PF614-MPAR-102 study
PremiumThe Fly
Ensysce secures IRB approval of final phase of PF614-MPAR-102 study
3M ago
ENSC
Ensysce Biosciences files to sell 20.34M shares of common stock for holders
PremiumThe FlyEnsysce Biosciences files to sell 20.34M shares of common stock for holders
3M ago
ENSC
Ensysce Biosciences Secures $2 Million Private Financing
Premium
Company Announcements
Ensysce Biosciences Secures $2 Million Private Financing
3M ago
8K
ENSC
Ensysce Biosciences secures second financing from 2025 agreement
Premium
The Fly
Ensysce Biosciences secures second financing from 2025 agreement
3M ago
ENSC
Ensysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
PremiumCompany Announcements
Ensysce Biosciences Announces Board Member Curtis Rosebraugh Resignation
4M ago
8K
ENSC
ENSC Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ENSC Earnings this Week: How Will it Perform?
4M ago
ENSC
Ensysce Biosciences Corrects Series B Preferred Stock Designation
PremiumCompany Announcements
Ensysce Biosciences Corrects Series B Preferred Stock Designation
4M ago
8K
ENSC
Ensysce Biosciences announces initiation of ‘Ask Me Anything’ series
PremiumThe Fly
Ensysce Biosciences announces initiation of ‘Ask Me Anything’ series
5M ago
ENSC
Ensysce Biosciences announces publication on MPAR technology
PremiumThe FlyEnsysce Biosciences announces publication on MPAR technology
5M ago
ENSC
Ensysce Biosciences initiates review of strategic alternatives
Premium
The Fly
Ensysce Biosciences initiates review of strategic alternatives
5M ago
ENSC
Ensysce Biosciences enrolls 50% of subjects in Phase 3 trial of PF614
Premium
The Fly
Ensysce Biosciences enrolls 50% of subjects in Phase 3 trial of PF614
6M ago
ENSC
Ensysce Biosciences expands global opioid patent portfolio
PremiumThe Fly
Ensysce Biosciences expands global opioid patent portfolio
6M ago
ENSC
Ensysce Biosciences Shareholders Approve Key Corporate Actions
PremiumCompany Announcements
Ensysce Biosciences Shareholders Approve Key Corporate Actions
6M ago
8K
ENSC
Ensysce Biosciences receives EU patent for ADHD therapy
PremiumThe Fly
Ensysce Biosciences receives EU patent for ADHD therapy
6M ago
ENSC
Ensysce’s PF614 Steps Forward in Phase 3 Post-Surgery Pain Trial: What Investors Should Watch
PremiumCompany Announcements
Ensysce’s PF614 Steps Forward in Phase 3 Post-Surgery Pain Trial: What Investors Should Watch
6M ago
ENSC
Ensysce Biosciences CEO says ‘positioned for continued momentum’
PremiumThe FlyEnsysce Biosciences CEO says ‘positioned for continued momentum’
6M ago
ENSC
Ensysce Biosciences initiates enrollment in Phase 3 trial of PF614
Premium
The Fly
Ensysce Biosciences initiates enrollment in Phase 3 trial of PF614
7M ago
ENSC
Ensysce Biosciences files to sell 4.6M shares of common stock for holders
Premium
The Fly
Ensysce Biosciences files to sell 4.6M shares of common stock for holders
8M ago
ENSC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >